• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Healthcare·RAINBOW.NS
Share

Rainbow Children's Medicare Limited Stocks

₹ 1457.8Last Updated 24.07.2026

Issuer Rating

5/7
Performance

Average

Risk

Low

Recommendation

Hold

Market Cap

₹ 1.58B

₹ 1457.8
Key Takeaways

Risk factor

Strong & resilient to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Rainbow Children's Medicare Limited is a leading Indian healthcare provider managing a network of multi-specialty hospitals dedicated to pediatric, obstetrics, and gynecology services. Its comprehensive child health offerings include general pediatrics, neonatology, various surgical disciplines, gastroenterology, hematology, oncology, psychology, dentistry, pulmonology, endocrinology, nephrology, nutrition, and psychiatric support. The company also delivers specialized care such as intensive care units, bone marrow and kidney transplants, cochlear implants, genetic and metabolic medicine, and therapeutic services like speech, language, and occupational therapy, alongside developmental and behavioral pediatrics. For women's health, Rainbow provides extensive obstetrics and gynecology services, including high-risk pregnancy management, painless delivery options, childbirth education, post-delivery support, well-woman check-ups, urogynecology, pre-pregnancy assessments, minimally invasive surgery, breast care, fetal medicine, and menopausal treatments. Furthermore, the company offers a full spectrum of fertility solutions, encompassing ovulation induction, various in-vitro fertilization techniques (such as ICSI and IMSI), intrauterine insemination, assisted hatching, cryopreservation, donor programs (sperm, oocyte, embryo), surgical sperm retrieval, and reproductive surgery. As of December 31, 2021, the company operated 14 hospitals and 3 clinics across 6 cities, providing a total of 1,500 beds. Established in 1998, its headquarters are situated in Hyderabad, India.

Company Valuation

Overvalued
2/7

Based on key historical and expected multiples, the stock is overvalued relative to its peers. In particular, the stock is overpriced on P/E, of fair value on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of RAINBOW.NS is 1552 and suggests 6.45% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recomme

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

26.07.2026 21:33

Revolut Valued at $115 Billion and a Record-Breaking Deal in Asia: Key Takeaways on IPOs as of July 26

26.07.2026 15:01

AI Tools to Combat Cognitive Biases: How Investors Can Use Them

25.07.2026 16:01

Small caps last week: New Nasdaq rules, AI hurting Tripadvisor, Archer's rotorcraft

25.07.2026 13:50

Chevron Discussed with the U.S. How to Protect Its Interests in Kazakhstan from the Effects of the War — WSJ

25.07.2026 13:01

The "Three Seas" Risk Zone, Tesla Hit by Expenses, and "Odyssey" — the Driving Force Behind Movie Theaters

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026